Contrast-enhanced ultrasound identifies early extrahepatic collateral contributing to residual hepatocellular tumor viability after transarterial chemoembolization

The mainstay of treatment for unresectable hepatocellular carcinoma is locoregional therapy including percutaneous ablation and transarterial chemo- and radioembolization. While monitoring for tumor response after transarterial chemoembolization is crucial, current imaging strategies are suboptimal....

Descripción completa

Detalles Bibliográficos
Autores principales: Gummadi, Sriharsha, Stanczak, Maria, Lyshchik, Andrej, Forsberg, Flemming, Shaw, Colette M., Eisenbrey, John R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Sonography
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5930180/
https://www.ncbi.nlm.nih.gov/pubmed/29721125
http://dx.doi.org/10.1016/j.radcr.2018.04.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5930180/
https://www.ncbi.nlm.nih.gov/pubmed/29721125
http://dx.doi.org/10.1016/j.radcr.2018.04.001

Ejemplares similares